Latin America Roundup: COFEPRIS seeks to boost production of biologics in Mexico
“Officials with Mexico’s Federal Commission for the Protection against Health Risks (COFEPRIS) have met with local biopharmaceutical manufacturers and academics, seeking to increase national production of biological and biosimilar therapies, the vast majority of which are currently imported. The project “promises not only to transform the medical landscape, but also to strengthen the national economy,” and promote both local and regional health self-sufficiency, the agency said. COFEPRIS did not detail which entities had taken part in the meetings, or a timeframe for the project…”